-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The production process of 2-(methylthio)-5-(tributylstanny)pyrimidine, commonly referred to as SYP-123, involves several stages, from the preparation of raw materials to the final product.
The process can be divided into three main steps: synthesis, purification, and formulation.
Synthesis:
The synthesis of SYP-123 involves several chemical reactions that convert raw materials into the desired product.
The initial step involves the synthesis of a substituted pyrimidine precursor, which is then reacted with a thioester to produce the thiopyrimidine moiety.
This is followed by the addition of a tributylstannyl group to the pyridine nucleus.
The final step involves the deprotection of the thioester group to yield the desired product.
Purification:
After the synthesis step, the product is typically purified to remove any impurities that may have been introduced during the synthesis process.
This can be achieved through various purification methods, such as crystallization, column chromatography, or high-performance liquid chromatography (HPLC).
The purification process is critical to ensure that the final product is of the required purity and quality.
Formulation:
The final step in the production process involves the formulation of SYP-123 into a suitable form for commercial use.
The formulation process can involve the addition of excipients, such as buffers or stabilizers, to ensure the stability and bioavailability of the product.
The formulation can also involve the encapsulation of the SYP-123 into a drug delivery system, such as a polymer matrix or liposome, to improve the pharmacokinetic properties of the drug.
Overall, the production process of SYP-123 involves several stages, each critical to the production of a high-quality and stable product.
The synthesis and purification steps must be carefully controlled to ensure the desired product is produced, while the formulation step is essential to ensure that the product is suitable for commercial use.
The production process must also adhere to strict regulatory guidelines to ensure the safety and efficacy of the product.
